Infinity Pharmaceuticals Ownership 2024 | Who Owns Infinity Pharmaceuticals Now?


OverviewForecastChart

Institutional Ownership

0.01%

Insider Ownership

2.36%

Retail Ownership

97.64%

Institutional Holders

3.00

Infinity Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----100-100.00%-Dec 31, 2023
XTX TOPCO LTD----181,068-100.00%-Dec 31, 2023

Infinity Pharmaceuticals's largest institutional shareholder is STEWARD PARTNERS INVESTMENT ADVISORY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----100-100.00%-Dec 31, 2023
XTX TOPCO LTD----181,068-100.00%-Dec 31, 2023

The largest Infinity Pharmaceuticals shareholder by % of total assets is STEWARD PARTNERS INVESTMENT ADVISORY, LLC. The company owns 0.00 shares of Infinity Pharmaceuticals (INFI), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----100-100.00%-Dec 31, 2023
XTX TOPCO LTD----181,068-100.00%-Dec 31, 2023

As of Dec 31 2023, Infinity Pharmaceuticals's largest institutional buyer is STEWARD PARTNERS INVESTMENT ADVISORY, LLC. The company purchased -0.10K stocks of INFI, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
XTX TOPCO LTD----181,068-100.00%-Dec 31, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----100-100.00%-Dec 31, 2023

As of Dec 31 2023, Infinity Pharmaceuticals's biggest institutional seller is XTX TOPCO LTD. The company sold -0.18M shares of INFI, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
XTX TOPCO LTD----181,068-100.00%-Dec 31, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----100-100.00%-Dec 31, 2023

Infinity Pharmaceuticals's largest sold out institutional shareholder by shares sold is XTX TOPCO LTD, sold -0.18M shares, valued at -, as of undefined.

Infinity Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.15%80,200--Mar 31, 2024
BRIDGEWAY FUNDS INC0.10%240,000--Mar 28, 2024
VANGUARD EXPLORER FUND0.09%1,053,408--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.05%9,578--Mar 28, 2024
Fidelity Commonwealth Trust II0.03%169,523--Aug 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%13,364--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%128,670--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,454--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%3,816,832--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.01%92,615--Mar 31, 2024
ALPS ETF Trust0.01%87,022--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.01%179,271--Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.01%265,397--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%748,298--Feb 29, 2024
Calvert Variable Products, Inc.0.00%6,863--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%65,713--Mar 31, 2024
GPS Funds I0.00%6,678--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%5,800--Mar 31, 2024
SA FUNDS INVESTMENT TRUST0.00%17,874--Mar 31, 2024
HC CAPITAL TRUST0.00%27,920--Mar 31, 2024
Principal Exchange-Traded Funds0.00%10,053--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%29,948--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%1,688--Mar 31, 2024
Global X Funds0.00%24,991--Jan 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%1,600--Mar 31, 2024
NORTHERN FUNDS0.00%46,700--Mar 28, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%317,619--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%17,300--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%217--Dec 31, 2023
RYDEX SERIES FUNDS0.00%834--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%12,018--Feb 29, 2024
EQ ADVISORS TRUST0.00%208,290--Mar 31, 2024
ProFunds0.00%1,872--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%640,938--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%3,432--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%298,971--Feb 29, 2024
PENN SERIES FUNDS INC0.00%3,400--Mar 28, 2024
RYDEX DYNAMIC FUNDS0.00%462--Dec 31, 2023
VALIC Co I0.00%32,445--Feb 29, 2024
Goldman Sachs ETF Trust0.00%9,847--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%11,675--Mar 31, 2024
Guggenheim Active Allocation Fund0.00%521--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%84--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%6,021--Mar 31, 2024
TIAA-CREF FUNDS0.00%203,275--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%67,111--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%8,294--Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%3,325--Dec 31, 2023
USAA MUTUAL FUNDS TRUST0.00%9,930--Jan 31, 2024
Brighthouse Funds Trust II0.00%33,123--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%3,573--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%9,285--Jan 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%75,100--Mar 31, 2024
ETF Series Solutions0.00%646--Jan 31, 2024
PROSHARES TRUST0.00%7,509--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%9,904--Feb 29, 2024
Blackstone Alternative Investment Funds0.00%1,300-2,500-65.79%Mar 31, 2023
Legg Mason Global Asset Management Trust0.00%120,000--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%4,968--Jan 31, 2024
Dimensional ETF Trust0.00%4,997--Jan 31, 2024
RUSSELL INVESTMENT FUNDS0.00%1,113--Mar 31, 2024
PACIFIC SELECT FUND0.00%32,342--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%7,598--Dec 31, 2023
Meeder Funds0.00%28--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%1,662--Jan 31, 2024
iSHARES TRUST0.00%73,140--Mar 31, 2024
Bridge Builder Trust0.00%12,474--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%15,563--Feb 29, 2024
BLACKROCK FUNDS0.00%12,438--Mar 28, 2024
Advisors' Inner Circle Fund III0.00%125--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,864--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%2,257--Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%18,700--Feb 29, 2024
John Hancock Funds II0.00%10,599--Feb 29, 2024

Infinity Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 80.20K shares, compromising 0.15% of its total assets.

Infinity Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 23350.00%
30 Sep, 232-95.65%
30 Jun, 2346-14.81%
31 Mar, 2354-18.18%
31 Dec, 2266-10.81%
30 Sep, 22741.37%
30 Jun, 2273-20.65%
31 Mar, 2292-11.54%
31 Dec, 21104-6.31%
30 Sep, 211117.77%
30 Jun, 2110318.39%
31 Mar, 218752.63%
31 Dec, 205735.71%
30 Sep, 2042-4.55%
30 Jun, 2044-6.38%
31 Mar, 20472.17%
31 Dec, 1946-9.80%
30 Sep, 1951-7.27%
30 Jun, 1955-12.70%
31 Mar, 1963-3.08%
31 Dec, 1865-1.52%
30 Sep, 1866-
30 Jun, 1866-2.94%
31 Mar, 18689.68%
31 Dec, 17625.08%
30 Sep, 1759-19.18%
30 Jun, 1773-14.12%
31 Mar, 1785-13.27%
31 Dec, 1698-1.01%
30 Sep, 1699-11.61%
30 Jun, 16112-6.67%
31 Mar, 16120-3.23%
31 Dec, 15124-12.68%
30 Sep, 151420.71%
30 Jun, 15141-6.00%
31 Mar, 15150-3.85%
31 Dec, 1415615.56%
30 Sep, 1413519.47%
30 Jun, 14113-3.42%
31 Mar, 14117-4.10%
31 Dec, 131222.52%
30 Sep, 13119-12.50%
30 Jun, 13136151.85%
31 Mar, 135420.00%
31 Dec, 124521.62%
30 Sep, 123737.04%
30 Jun, 122735.00%
31 Mar, 1220-
31 Dec, 1120-4.76%
30 Sep, 112123.53%
30 Jun, 11176.25%
31 Mar, 111633.33%
31 Dec, 1012-7.69%
30 Sep, 1013-23.53%
30 Jun, 101721.43%
31 Mar, 101416.67%
31 Dec, 0912-14.29%
30 Sep, 0914-
30 Jun, 091475.00%
31 Mar, 098-11.11%
31 Dec, 08912.50%
30 Sep, 08833.33%
30 Jun, 086-14.29%
31 Mar, 087-22.22%
31 Dec, 079-
30 Sep, 07912.50%
30 Jun, 07833.33%
31 Mar, 076-40.00%
31 Dec, 0610-
30 Sep, 0610-
30 Mar, 061-

As of 31 Dec 23, 3 institutions are holding Infinity Pharmaceuticals's shares, representing an increase of 50.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 235,700-96.85%
30 Sep, 23181,168-99.10%
30 Jun, 2320,095,4453.86%
31 Mar, 2319,347,749-22.74%
31 Dec, 2225,043,076-18.82%
30 Sep, 2230,847,1352.62%
30 Jun, 2230,060,603-22.59%
31 Mar, 2238,834,154-6.59%
31 Dec, 2141,574,341-11.40%
30 Sep, 2146,924,1627.16%
30 Jun, 2143,787,3564.55%
31 Mar, 2141,883,45928.81%
31 Dec, 2032,515,7266.22%
30 Sep, 2030,610,47410.13%
30 Jun, 2027,793,970-0.46%
31 Mar, 2027,922,316-1.51%
31 Dec, 1928,350,859-3.37%
30 Sep, 1929,339,914-4.42%
30 Jun, 1930,697,349-0.74%
31 Mar, 1930,926,0500.50%
31 Dec, 1830,773,4943.76%
30 Sep, 1829,657,3655.86%
30 Jun, 1828,015,263-1.24%
31 Mar, 1828,365,68610.36%
31 Dec, 1725,703,597-6.71%
30 Sep, 1727,553,160-19.49%
30 Jun, 1734,222,683-11.34%
31 Mar, 1738,600,7960.09%
31 Dec, 1638,564,246-2.78%
30 Sep, 1639,668,779-2.08%
30 Jun, 1640,513,078-11.96%
31 Mar, 1646,014,147-7.32%
31 Dec, 1549,650,394-15.20%
30 Sep, 1558,551,19015.90%
30 Jun, 1550,518,4582.35%
31 Mar, 1549,360,6766.92%
31 Dec, 1446,165,0672.21%
30 Sep, 1445,168,665-3.09%
30 Jun, 1446,609,168-3.02%
31 Mar, 1448,062,4577.06%
31 Dec, 1344,893,060-6.34%
30 Sep, 1347,931,4852.68%
30 Jun, 1346,678,719157.70%
31 Mar, 1318,113,86438.03%
31 Dec, 1213,123,0577.97%
30 Sep, 1212,154,02559.26%
30 Jun, 127,631,679-5.42%
31 Mar, 128,069,36218.42%
31 Dec, 116,814,46813.52%
30 Sep, 116,002,92218.71%
30 Jun, 115,056,8105.04%
31 Mar, 114,814,30510.21%
31 Dec, 104,368,195-5.10%
30 Sep, 104,603,1770.39%
30 Jun, 104,585,1821.14%
31 Mar, 104,533,32911.53%
31 Dec, 094,064,512-30.90%
30 Sep, 095,882,30388.87%
30 Jun, 093,114,460-39.44%
31 Mar, 095,142,47335.34%
31 Dec, 083,799,729-33.12%
30 Sep, 085,681,29075.79%
30 Jun, 083,231,8921.81%
31 Mar, 083,174,493-4.87%
31 Dec, 073,337,04315.89%
30 Sep, 072,879,4072.29%
30 Jun, 072,814,887175.67%
31 Mar, 071,021,114-62.59%
31 Dec, 062,729,38931.59%
30 Sep, 062,074,204-
30 Mar, 061,000-

Infinity Pharmaceuticals (INFI) has 5.70K shares outstanding as of 31 Dec 23, down -96.85% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 230.01%15.63%
30 Sep, 230.20%0.04%
30 Jun, 2322.36%4.77%
31 Mar, 2321.64%2.75%
31 Dec, 2228.06%2.36%
30 Sep, 2234.51%3.04%
30 Jun, 2233.71%1.78%
31 Mar, 2243.56%2.00%
31 Dec, 2146.67%1.67%
30 Sep, 2152.86%2.17%
30 Jun, 2149.39%1.61%
31 Mar, 2155.31%1.87%
31 Dec, 2054.32%2.12%
30 Sep, 2050.59%2.16%
30 Jun, 2048.39%2.04%
31 Mar, 2048.69%1.97%
31 Dec, 1949.75%1.88%
30 Sep, 1951.45%1.77%
30 Jun, 1953.91%1.83%
31 Mar, 1954.33%1.76%
31 Dec, 1855.54%2.04%
30 Sep, 1852.17%2.08%
30 Jun, 1850.06%1.67%
31 Mar, 1854.67%2.13%
31 Dec, 1750.68%1.71%
30 Sep, 1754.41%1.18%
30 Jun, 1767.83%1.16%
31 Mar, 1776.55%1.27%
31 Dec, 1677.74%1.21%
30 Sep, 1680.00%1.19%
30 Jun, 1681.95%0.94%
31 Mar, 1693.26%0.92%
31 Dec, 15100.86%0.71%
30 Sep, 15119.03%1.12%
30 Jun, 15102.94%1.01%
31 Mar, 15100.86%1.13%
31 Dec, 1494.62%1.10%
30 Sep, 1492.88%1.01%
30 Jun, 1496.01%0.97%
31 Mar, 1499.41%1.13%
31 Dec, 1393.65%0.94%
30 Sep, 1399.75%1.05%
30 Jun, 1397.42%6.73%
31 Mar, 1338.04%3.70%
31 Dec, 1232.06%2.23%
30 Sep, 1237.93%4.77%
30 Jun, 1228.20%3.11%
31 Mar, 1230.14%4.60%
31 Dec, 1125.60%5.05%
30 Sep, 1122.51%6.21%
30 Jun, 1119.03%5.78%
31 Mar, 1118.14%6.64%
31 Dec, 1016.53%5.41%
30 Sep, 1017.48%5.74%
30 Jun, 1017.44%5.85%
31 Mar, 1017.27%7.18%
31 Dec, 0915.51%3.07%
30 Sep, 0922.49%15.82%
30 Jun, 0911.92%3.03%
31 Mar, 0919.85%6.52%
31 Dec, 0817.45%2.11%
30 Sep, 0828.75%10.71%
30 Jun, 0816.38%6.29%
31 Mar, 0816.13%5.52%
31 Dec, 0717.10%7.91%
30 Sep, 0714.71%7.06%
30 Jun, 0714.43%52.03%
31 Mar, 075.27%2.69%
31 Dec, 0613.98%12.39%
30 Sep, 0610.62%-
30 Mar, 060.01%-

As of 31 Dec 23, Infinity Pharmaceuticals is held by 0.01% institutional shareholders, representing a 15.63% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 233200.00%
30 Sep, 231-88.89%
30 Jun, 239-25.00%
31 Mar, 2312-47.83%
31 Dec, 2223-8.00%
30 Sep, 2225-16.67%
30 Jun, 223020.00%
31 Mar, 2225-32.43%
31 Dec, 2137-32.73%
30 Sep, 2155-3.51%
30 Jun, 2157-10.94%
31 Mar, 2164137.04%
31 Dec, 2027125.00%
30 Sep, 2012-25.00%
30 Jun, 201633.33%
31 Mar, 2012-
31 Dec, 191233.33%
30 Sep, 199-43.75%
30 Jun, 1916-27.27%
31 Mar, 1922-26.67%
31 Dec, 18307.14%
30 Sep, 1828-9.68%
30 Jun, 183110.71%
31 Mar, 182812.00%
31 Dec, 172513.64%
30 Sep, 1722-24.14%
30 Jun, 1729-19.44%
31 Mar, 1736-14.29%
31 Dec, 164210.53%
30 Sep, 1638-29.63%
30 Jun, 1654-8.47%
31 Mar, 165920.41%
31 Dec, 1549-20.97%
30 Sep, 1562-15.07%
30 Jun, 1573-17.98%
31 Mar, 15898.54%
31 Dec, 148232.26%
30 Sep, 146231.91%
30 Jun, 1447-14.55%
31 Mar, 1455-6.78%
31 Dec, 13599.26%
30 Sep, 1354-50.91%
30 Jun, 13110197.30%
31 Mar, 13375.71%
31 Dec, 123520.69%
30 Sep, 1229141.67%
30 Jun, 121220.00%
31 Mar, 1210-23.08%
31 Dec, 11138.33%
30 Sep, 1112-
30 Jun, 111271.43%
31 Mar, 11740.00%
31 Dec, 10525.00%
30 Sep, 104-33.33%
30 Jun, 106-25.00%
31 Mar, 10814.29%
31 Dec, 09716.67%
30 Sep, 096-57.14%
30 Jun, 0914366.67%
31 Mar, 093-40.00%
31 Dec, 08566.67%
30 Sep, 08350.00%
30 Jun, 082-50.00%
31 Mar, 084-20.00%
31 Dec, 07566.67%
30 Sep, 073-25.00%
30 Jun, 074-
31 Mar, 074-20.00%
31 Dec, 065-50.00%
30 Sep, 0610-
30 Mar, 061-

3 institutional shareholders have increased their position in INFI stock as of 31 Dec 23 compared to 1 in the previous quarter (a 200.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--
30 Sep, 23--100.00%
30 Jun, 231525.00%
31 Mar, 2312-36.84%
31 Dec, 2219-26.92%
30 Sep, 22268.33%
30 Jun, 2224-36.84%
31 Mar, 22388.57%
31 Dec, 213525.00%
30 Sep, 212821.74%
30 Jun, 2123187.50%
31 Mar, 218-27.27%
31 Dec, 201110.00%
30 Sep, 201042.86%
30 Jun, 207-50.00%
31 Mar, 2014-
31 Dec, 1914-6.67%
30 Sep, 191525.00%
30 Jun, 1912-33.33%
31 Mar, 191820.00%
31 Dec, 1815-6.25%
30 Sep, 181623.08%
30 Jun, 1813-18.75%
31 Mar, 1816-33.33%
31 Dec, 1724-4.00%
30 Sep, 1725-
30 Jun, 1725-16.67%
31 Mar, 17303.45%
31 Dec, 1629-6.45%
30 Sep, 1631-13.89%
30 Jun, 16369.09%
31 Mar, 1633-26.67%
31 Dec, 1545-13.46%
30 Sep, 15528.33%
30 Jun, 154871.43%
31 Mar, 1528-28.21%
31 Dec, 14395.41%
30 Sep, 143715.63%
30 Jun, 14323.23%
31 Mar, 1431-8.82%
31 Dec, 1334-17.07%
30 Sep, 1341355.56%
30 Jun, 13912.50%
31 Mar, 13860.00%
31 Dec, 125-
30 Sep, 125-37.50%
30 Jun, 12833.33%
31 Mar, 12650.00%
31 Dec, 114-33.33%
30 Sep, 116100.00%
30 Jun, 113-25.00%
31 Mar, 114-
31 Dec, 104-33.33%
30 Sep, 106-40.00%
30 Jun, 1010233.33%
31 Mar, 10350.00%
31 Dec, 092-50.00%
30 Sep, 094-
30 Jun, 09--100.00%
31 Mar, 092-
31 Dec, 082-
30 Sep, 082-
30 Jun, 082-33.33%
31 Mar, 083-
31 Dec, 073-25.00%
30 Sep, 074300.00%
30 Jun, 071-
31 Mar, 071-50.00%
31 Dec, 062-
30 Sep, 06--
30 Mar, 06--

- institutional shareholders have reduced their position in INFI stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 23350.00%5,700-96.85%0.01%15.63%3200.00%--
30 Sep, 232-95.65%181,168-99.10%0.20%0.04%1-88.89%--100.00%
30 Jun, 2346-14.81%20,095,4453.86%22.36%4.77%9-25.00%1525.00%
31 Mar, 2354-18.18%19,347,749-22.74%21.64%2.75%12-47.83%12-36.84%
31 Dec, 2266-10.81%25,043,076-18.82%28.06%2.36%23-8.00%19-26.92%
30 Sep, 22741.37%30,847,1352.62%34.51%3.04%25-16.67%268.33%
30 Jun, 2273-20.65%30,060,603-22.59%33.71%1.78%3020.00%24-36.84%
31 Mar, 2292-11.54%38,834,154-6.59%43.56%2.00%25-32.43%388.57%
31 Dec, 21104-6.31%41,574,341-11.40%46.67%1.67%37-32.73%3525.00%
30 Sep, 211117.77%46,924,1627.16%52.86%2.17%55-3.51%2821.74%
30 Jun, 2110318.39%43,787,3564.55%49.39%1.61%57-10.94%23187.50%
31 Mar, 218752.63%41,883,45928.81%55.31%1.87%64137.04%8-27.27%
31 Dec, 205735.71%32,515,7266.22%54.32%2.12%27125.00%1110.00%
30 Sep, 2042-4.55%30,610,47410.13%50.59%2.16%12-25.00%1042.86%
30 Jun, 2044-6.38%27,793,970-0.46%48.39%2.04%1633.33%7-50.00%
31 Mar, 20472.17%27,922,316-1.51%48.69%1.97%12-14-
31 Dec, 1946-9.80%28,350,859-3.37%49.75%1.88%1233.33%14-6.67%
30 Sep, 1951-7.27%29,339,914-4.42%51.45%1.77%9-43.75%1525.00%
30 Jun, 1955-12.70%30,697,349-0.74%53.91%1.83%16-27.27%12-33.33%
31 Mar, 1963-3.08%30,926,0500.50%54.33%1.76%22-26.67%1820.00%
31 Dec, 1865-1.52%30,773,4943.76%55.54%2.04%307.14%15-6.25%
30 Sep, 1866-29,657,3655.86%52.17%2.08%28-9.68%1623.08%
30 Jun, 1866-2.94%28,015,263-1.24%50.06%1.67%3110.71%13-18.75%
31 Mar, 18689.68%28,365,68610.36%54.67%2.13%2812.00%16-33.33%
31 Dec, 17625.08%25,703,597-6.71%50.68%1.71%2513.64%24-4.00%
30 Sep, 1759-19.18%27,553,160-19.49%54.41%1.18%22-24.14%25-
30 Jun, 1773-14.12%34,222,683-11.34%67.83%1.16%29-19.44%25-16.67%
31 Mar, 1785-13.27%38,600,7960.09%76.55%1.27%36-14.29%303.45%
31 Dec, 1698-1.01%38,564,246-2.78%77.74%1.21%4210.53%29-6.45%
30 Sep, 1699-11.61%39,668,779-2.08%80.00%1.19%38-29.63%31-13.89%
30 Jun, 16112-6.67%40,513,078-11.96%81.95%0.94%54-8.47%369.09%
31 Mar, 16120-3.23%46,014,147-7.32%93.26%0.92%5920.41%33-26.67%
31 Dec, 15124-12.68%49,650,394-15.20%100.86%0.71%49-20.97%45-13.46%
30 Sep, 151420.71%58,551,19015.90%119.03%1.12%62-15.07%528.33%
30 Jun, 15141-6.00%50,518,4582.35%102.94%1.01%73-17.98%4871.43%
31 Mar, 15150-3.85%49,360,6766.92%100.86%1.13%898.54%28-28.21%
31 Dec, 1415615.56%46,165,0672.21%94.62%1.10%8232.26%395.41%
30 Sep, 1413519.47%45,168,665-3.09%92.88%1.01%6231.91%3715.63%
30 Jun, 14113-3.42%46,609,168-3.02%96.01%0.97%47-14.55%323.23%
31 Mar, 14117-4.10%48,062,4577.06%99.41%1.13%55-6.78%31-8.82%
31 Dec, 131222.52%44,893,060-6.34%93.65%0.94%599.26%34-17.07%
30 Sep, 13119-12.50%47,931,4852.68%99.75%1.05%54-50.91%41355.56%
30 Jun, 13136151.85%46,678,719157.70%97.42%6.73%110197.30%912.50%
31 Mar, 135420.00%18,113,86438.03%38.04%3.70%375.71%860.00%
31 Dec, 124521.62%13,123,0577.97%32.06%2.23%3520.69%5-
30 Sep, 123737.04%12,154,02559.26%37.93%4.77%29141.67%5-37.50%
30 Jun, 122735.00%7,631,679-5.42%28.20%3.11%1220.00%833.33%
31 Mar, 1220-8,069,36218.42%30.14%4.60%10-23.08%650.00%
31 Dec, 1120-4.76%6,814,46813.52%25.60%5.05%138.33%4-33.33%
30 Sep, 112123.53%6,002,92218.71%22.51%6.21%12-6100.00%
30 Jun, 11176.25%5,056,8105.04%19.03%5.78%1271.43%3-25.00%
31 Mar, 111633.33%4,814,30510.21%18.14%6.64%740.00%4-
31 Dec, 1012-7.69%4,368,195-5.10%16.53%5.41%525.00%4-33.33%
30 Sep, 1013-23.53%4,603,1770.39%17.48%5.74%4-33.33%6-40.00%
30 Jun, 101721.43%4,585,1821.14%17.44%5.85%6-25.00%10233.33%
31 Mar, 101416.67%4,533,32911.53%17.27%7.18%814.29%350.00%
31 Dec, 0912-14.29%4,064,512-30.90%15.51%3.07%716.67%2-50.00%
30 Sep, 0914-5,882,30388.87%22.49%15.82%6-57.14%4-
30 Jun, 091475.00%3,114,460-39.44%11.92%3.03%14366.67%--100.00%
31 Mar, 098-11.11%5,142,47335.34%19.85%6.52%3-40.00%2-
31 Dec, 08912.50%3,799,729-33.12%17.45%2.11%566.67%2-
30 Sep, 08833.33%5,681,29075.79%28.75%10.71%350.00%2-
30 Jun, 086-14.29%3,231,8921.81%16.38%6.29%2-50.00%2-33.33%
31 Mar, 087-22.22%3,174,493-4.87%16.13%5.52%4-20.00%3-
31 Dec, 079-3,337,04315.89%17.10%7.91%566.67%3-25.00%
30 Sep, 07912.50%2,879,4072.29%14.71%7.06%3-25.00%4300.00%
30 Jun, 07833.33%2,814,887175.67%14.43%52.03%4-1-
31 Mar, 076-40.00%1,021,114-62.59%5.27%2.69%4-20.00%1-50.00%
31 Dec, 0610-2,729,38931.59%13.98%12.39%5-50.00%2-
30 Sep, 0610-2,074,204-10.62%-10---
30 Mar, 061-1,000-0.01%-1---

Infinity Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 12, 2023Perkins Adelene Qdirector-S-SaleSell410,196$0.07$28.71K1,175,291
Aug 04, 2022Peluso Stephanedirector Chief Scientific OfficerS-SaleBuy14,994$0.66$9.93K37,052

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 12, 2023Perkins Adelene Qdirector-S-SaleSell410,196$0.07$28.71K1,175,291
Sep 12, 2023Perkins Adelene Qdirector-M-ExemptSell768,133---
Aug 04, 2022Peluso Stephanedirector Chief Scientific OfficerM-ExemptSell50,000---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 12, 2023Perkins Adelene Qdirector-M-ExemptBuy768,133--1,585,487
Sep 12, 2023Perkins Adelene Qdirector-S-SaleSell410,196$0.07$28.71K1,175,291
Sep 12, 2023Perkins Adelene Qdirector-M-ExemptSell768,133---
Aug 04, 2022Peluso Stephanedirector Chief Scientific OfficerS-SaleBuy14,994$0.66$9.93K37,052
Aug 04, 2022Peluso Stephanedirector Chief Scientific OfficerM-ExemptSell50,000---
Jun 16, 2022EVNIN ANTHONY Bdirector-A-AwardBuy46,378$0.68$31.49K215,403
Jun 16, 2022EVNIN ANTHONY Bdirector A-AwardBuy45,000--45,000
Jun 16, 2022EVNIN ANTHONY Bdirector-A-AwardBuy45,000$0.68$30.56K45,000
Jun 16, 2022BEIER DAVID Wdirector A-AwardBuy45,000--45,000
Jun 16, 2022BEIER DAVID Wdirector-A-AwardBuy45,000$0.68$30.56K45,000
Jun 16, 2022GAYNOR RICHARDdirector A-AwardBuy45,000--45,000
Jun 16, 2022GAYNOR RICHARDdirector-A-AwardBuy45,000$0.68$30.56K45,000
Jun 16, 2022Agresta Samueldirector A-AwardBuy45,000--45,000
Jun 16, 2022Agresta Samueldirector-A-AwardBuy45,000$0.68$30.56K45,000
Jun 16, 2022SELBY NORMAN Cdirector A-AwardBuy45,000--45,000
Jun 16, 2022SCHWARTZ BRIANdirector A-AwardBuy45,000--45,000
Jun 16, 2022SCHWARTZ BRIANdirector-A-AwardBuy45,000$0.68$30.56K45,000
Jun 16, 2022SCHWARTZ BRIANdirector-A-AwardBuy30,919$0.68$20.99K30,919
Mar 31, 2022KANGO SUJAYdirector A-AwardBuy90,000--90,000
Mar 31, 2022KANGO SUJAYdirector-A-AwardBuy90,000$1.13$101.70K90,000

The last insider sell of Infinity Pharmaceuticals's stock was made by Perkins Adelene Q on Sep 12 2023, selling 410,196 shares at $0.07 per share (valued at $28.71K).

Infinity Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20231250.00%
Q3 202211100.00%
Q2 20226--
Q1 20226--
Q3 202143133.33%
Q2 202191900.00%
Q1 2021-6-
Q4 20204--
Q2 20207--
Q1 20209--
Q4 2019-3-
Q2 201910--
Q1 20195--
Q4 20181711700.00%
Q3 20181250.00%
Q2 20182812800.00%
Q1 201891900.00%
Q4 20177--
Q3 20173--
Q2 201717--

1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by Infinity Pharmaceuticals's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-1-
Q3 2022-1-
Q2 2022---
Q1 2022---
Q3 2021---
Q2 2021---
Q1 2021-6-
Q4 2020---
Q2 2020---
Q1 2020---
Q4 2019---
Q2 2019---
Q1 2019---
Q4 20181711700.00%
Q3 2018-2-
Q2 20181211200.00%
Q1 2018-1-
Q4 20177--
Q3 2017---
Q2 2017---

As of Q3 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Infinity Pharmaceuticals's stocks.

Infinity Pharmaceuticals Peer Ownership


TickerCompany
NUVBNuvation Bio Inc.
NXTCNextCure, Inc.
EWTXEdgewise Therapeutics, Inc.
ERASErasca, Inc.
ADTXAditxt, Inc.
CTMXCytomX Therapeutics, Inc.
REVBRevelation Biosciences, Inc.
GBIOGeneration Bio Co.
SQZSQZ Biotechnologies Company
DRMADermata Therapeutics, Inc.
KRONKronos Bio, Inc.
CCCCC4 Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
ASMBAssembly Biosciences, Inc.
NRBONeuroBo Pharmaceuticals, Inc.
UNCYUnicycive Therapeutics, Inc.
TARAProtara Therapeutics, Inc.
TRVITrevi Therapeutics, Inc.
NLTXNeurogene Inc.
CMRXChimerix, Inc.
LYRALyra Therapeutics, Inc.
TILInstil Bio, Inc.

INFI Ownership FAQ


Infinity Pharmaceuticals is owned by institutional shareholders (0.01%), insiders (2.36%), and public (97.64%). The largest institutional shareholder of Infinity Pharmaceuticals is STEWARD PARTNERS INVESTMENT ADVISORY, LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.15% of total shares).

Infinity Pharmaceuticals's major institutional shareholders are STEWARD PARTNERS INVESTMENT ADVISORY, LLC, and XTX TOPCO LTD. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 3 institutional shareholders of Infinity Pharmaceuticals.

STEWARD PARTNERS INVESTMENT ADVISORY, LLC owns 0 shares of Infinity Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, XTX TOPCO LTD holds 0 shares of Infinity Pharmaceuticals (INFI), compromising 0% of the company, valued at $0.